Others

Astrazeneca Pharma India Ltd. - Board to consider Interim Dividend

| Updated on July 29, 2019 Published on July 29, 2019

AstraZeneca Pharma India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 07, 2019, inter alia, to:

1. consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2019

2. consider declaration of an Interim Dividend to the equity shareholders of the Company for the financial year 2019-20

Further, the ‘Trading Window’ remains closed for all Designated Persons, from June 16, 2019 to August 09, 2019 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of lnsider Trading) Regulations 2015.

Pdf Link: Astrazeneca Pharma India Ltd. - Board to consider Interim Dividend

Source : BSE - www.bseindia.com

Published on July 29, 2019
This article is closed for comments.
Please Email the Editor